Katharina Staufer - Concepedia

Author

Katharina Staufer

Also Known As

Federico Simonetta, K Staufer, K. STAUFER, K. Staufer, Katharina Staufer, Simonetta Federico, Staufer, Katharina, Yasaman Vali

128

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Universität Hamburg University Medical Center Hamburg-Eppendorf Medical University of Graz University Hospital of Bern

About

Katharina Staufer is an author at Medical University of Vienna specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	595
2	Health Sciences	2	2	135
3	Public Health	2	2	53
4	Engineering	1	1	63
5	Emergency Medicine	1	1	33

Katharina Staufer

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer, Gastroenterology HepatologyHepatitis CViral HepatitisRapid Virological ResponseAntiviral Therapy	2008	252
Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma Kornelius Schulze, Christin Gasch, Katharina Staufer, International Journal of Cancer	2013	245
Coagulation parameters and major bleeding in critically ill patients with cirrhosis Andreas Drolz, Thomas Horvatits, Kevin Roedl, Hepatology	2016	192
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Journal of Hepatology	2022	170
Urinary ethyl glucuronide as a novel screening tool in patients pre- and post–liver transplantation improves detection of alcohol consumption Katharina Staufer, Hilke Andresen, Eik Vettorazzi, Hepatology	2011	132
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells Nicole Grabinski, Florian Ewald, Bianca T. Hofmann, Molecular Cancer	2012	120
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma Florian Ewald, Nicole Grabinski, Astrid Grottke, International Journal of Cancer Chemoprevention StrategyImmunologyPathologyCholangiopathiesMtor Treatment	2013	86
Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease Katharina Staufer, Emina Halilbasic, Walter Spindelboeck, United European Gastroenterology Journal	2019	82
Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal—a Case Series Magdalena Eilenberg, Felix B. Langer, Andrea Beer, Obesity Surgery	2017	81
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3 Péter Ferenci, H. Brünner, Hermann Laferl, Hepatology	2008	73

Page 1